SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 197.85+3.0%Feb 2 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Wallace Rivers who wrote (29089)7/26/1999 5:18:00 PM
From: Biomaven  Read Replies (2) of 32384
 
Wallace,

Let me support Henry here. In fact the BTK index has been dominated by the big first tier biotechs, which form the majority of the index. Even though it is dollar weighted on a quarterly basis, the consistent outperformance of the first tier over the past few years has swamped the smaller companies in the index. The only other available biotech index, the IXBT, is no better, because although it is much more broadly based, it is cap weighted, and thus swamped by AMGN.

In fact there is no published biotech index that tells you how the "typical" biotech is doing (as does the geometrically-weighted Value Line index for most stocks).

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News